Manni Kantipudi

Manni Kantipudi joined Aragen in 2007 as President. He is presently CEO and member of the Board of Directors, responsible for the overall growth, strategy, M&A and culture of the company. In 2021, Mr Kantipudi spearheaded GVK BIO’s brand transformation into Aragen Life Sciences.

Since 2007, Mr Kantipudi has steered the company into becoming a leading R&D and manufacturing solutions provider to the global life science industry. He drove the acquisition of a biologics service provider in the US in 2014 (Aragen Bioscience) making GVK BIO (now known as Aragen) one of the first companies out of India to offer small and large molecule solutions.

Mr. Kantipudi has also been keenly involved in shaping company culture. Aragen was declared a Great Place to Work in 2020 and recertified in 2021, a first for a biopharmaceutical services company in India.

Prior to joining Aragen, Mr Kantipudi spent 16 years in the technology industry, holding various leadership and global positions in Asia and USA for Intel Corporation. He served as the Head of Intel India, the CIO of Intel Asia, and was responsible for the software in Intel’s WI-FI product line, Centrino.